Treatment Adherence and Compliance in Children and Adolescents on ADHD [attention-deficit hyperactivity disorder] Medication and Emotional Expression in Clinical Practice.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2009
At a glance
- Drugs Atomoxetine; Central nervous system stimulants
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms COMPLY
- Sponsors Eli Lilly
- 28 Aug 2009 Actual patient number (518) added as reported by ClinicalTrials.gov.
- 28 Aug 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 28 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.